Prediction: Pfizer Will Beat the Market in Five Years
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Understand which index funds are best for IRAs in 2024, with guidance on diversification, costs, and long-term retirement goals.
24,195 articlesPfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
When great growth ideas stumble, the long-term case often remains intact. This piece examines two names that have fal...
All three major U.S. benchmarks finished the session at new closing highs for 2026, signaling broad market strength a...
Poet Technologies rose today amid broader AI stock swings. This guide explains what moved the stock, what to watch go...
Midyear market shifts put Buffett's moat concept under stress as MOAT slips while the broad market climbs. Here’s wha...
June volatility has weighed on semiconductor stocks, but a window is emerging for selective buys. Here are three name...
Nebius Group has rocketed more than 240% this year. Before you jump in, learn how to weigh momentum against fundament...
Five-year horizons test even strong crypto theses. This article breaks down XRP's potential paths and practical steps...
July began with AI-driven headlines shifting attention from headlines to execution. This guide breaks down how stock ...
A two-ETF monthly income portfolio aims to replace $75,000 salary retirement by pairing equity income with tax-effici...
A notable fund boosted its Hexcel stake to roughly 23% of its portfolio after a $7.5 million purchase, sending the st...
As investors look toward talen (tln) 2025 earnings, the Q4 transcript becomes the compass for revenue, margins, and g...